-W H Wilson Tang Researcher Activity Profile

Research Author Detailed Information 

W H Wilson Tang Publication Rate By Year

W H Wilson Tang has published 1 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 18 paper(s) in 2007, 16 paper(s) in 2008, for a total of 37 research publications in total.

W H Wilson Wh Tang Author Information

LAST NAME: tang

FIRST NAME: W H Wilson

INITIALS: wh

AFFILIATION:

Papers

W H Wilson Tang's Publication Record

1. Preventing venous thromboembolism in cardiology and cardiac surgery. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
2. [Role of neurokinin-1 receptor in lung injury in rats with acute necrotizing pancreatitis] Year Published: 2003
Department of General Surgery, Zhong-Da Hospital, Southeast University, Nanjing 210009, Jiangsu, China. shixined@hotmail.com
3. Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy. Year Published: 2004
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Desk F25, Cleveland, OH 44195, USA. tangw@ccf.org
4. [Follow-up study on psychic and neuropathic delayed effects of acute organophosphorus pesticides poisoning] Year Published: 2005
Shandong Institute of Occupational Disease, Jinan 250062, China.
5. [An approach to male infertility from economic sociology] Year Published: 2007
Department of Urology, the Third Hospital of Peking University, Beijing 100083, China.
6. PPARgamma agonists: safety issues in heart failure. Year Published: 2007
Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, OH 44195, USA. tangw@ccf.org
7. Expression of periostin and its clinicopathological relevance in gastric cancer. Year Published: 2007
Department of General Surgery, Affiliated Zhong-Da Hospital, Southeast University, Nanjing 210009, Jiangsu Province, China. lijunshenghd@126.com
8. [An approach to male infertility from economic sociology] Year Published: 2007
Department of Urology, the Third Hospital of Peking University, Beijing 100083, China.
9. Exploring new drugs for heart failure: the case of urocortin. Year Published: 2007
10. Using echocardiography in cardiac resynchronization therapy. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
11. PPARgamma agonists: safety issues in heart failure. Year Published: 2007
Department of Cardiovascular Medicine, The Cleveland Clinic, Cleveland, OH 44195, USA. tangw@ccf.org
12. Pharmacologic therapy for acute heart failure. Year Published: 2007
Cleveland Clinic, Cleveland, OH, USA.
13. The year in heart failure. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
14. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Departments of Dermatology and Internal Medicine, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109.
15. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Department of Dermatology, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
16. A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA. tangw@ccf.org
17. The year in heart failure. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
18. A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus. Year Published: 2007
Department of Cardiovascular Medicine, Cleveland Clinic, OH 44195, USA. tangw@ccf.org
19. Pharmacologic therapy for acute heart failure. Year Published: 2007
Cleveland Clinic, Cleveland, OH, USA. tangw@ccf.org
20. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Department of Dermatology, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
21. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? Year Published: 2008
Section of Heart Failure and Cardiac Transplantation, the Cleveland Clinic, Cleveland, Ohio 44195, USA.
22. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? Year Published: 2008
Section of Heart Failure and Cardiac Transplantation, the Cleveland Clinic, Cleveland, Ohio 44195, USA.
23. Vasopressin receptor antagonists in heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic, OH, USA. HOBBSR@ccf.org
24. Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
25. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA. tangw@ccf.org
26. Pharmacologic therapy for acute heart failure. Year Published: 2007
Cleveland Clinic, Cleveland, OH, USA. tangw@ccf.org
27. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA. tangw@ccf.org
28. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure. Year Published: 2008
University of California at San Francisco, San Francisco, CA.
29. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Use of Cardiac Troponin and B-Type Natriuretic Peptide or N-Terminal proB-Type Natriuretic Peptide for Etiologies Other than Acute Coronary Syndromes and Heart Failure. Year Published: 2008
University of California at San Francisco, San Francisco, CA.
30. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Year Published: 2008
University of California at San Francisco, San Francisco, CA, USA.
31. Vasopressin receptor antagonists in heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic, OH, USA. HOBBSR@ccf.org
32. Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure. Year Published: 2008
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA. tangw@ccf.org
33. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biomarkers of Heart Failure. Year Published: 2008
Hennepin County Medical Center, Minneapolis, MN, USA.
34. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Year Published: 2008
Cleveland Clinic, Foundation, Cleveland, OH, USA.
35. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Year Published: 2008
Cleveland Clinic, Foundation, Cleveland, OH, USA.
36. Outcomes of patients with stable heart failure undergoing elective noncardiac surgery. Year Published: 2008
Department of Hospital Medicine, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. caio@ccf.org
37. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Year Published: 2008
Cleveland Clinic, Foundation, Cleveland, OH, USA.